MapLight Therapeutics, Inc. (MPLT) vs Phathom Pharmaceuticals, Inc. (PHAT)
MapLight Therapeutics, Inc. and Phathom Pharmaceuticals, Inc. are both Biotechnology companies. MapLight Therapeutics, Inc. and Phathom Pharmaceuticals, Inc. are of similar size ($587.7M and $572.8M). MapLight Therapeutics, Inc. has the higher net margin (0.00% vs −41.3%) and the lower return on invested capital (−348.4% vs 0.00%). Across the 12 metrics below, Phathom Pharmaceuticals, Inc. leads on 7 and MapLight Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | MPLT | PHAT | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 82.92% | 65.16% |
| Operating margin | 0.00% | (16.96%) | 0.00% |
| Net margin | 0.00% | (41.34%) | 0.00% |
| Free cash flow margin | 0.00% | (15.40%) | 0.00% |
| Return on equity | (297.18%) | 26.42% | (57.72%) |
| Return on assets | (124.79%) | (34.32%) | (49.22%) |
| Return on invested capital | (348.44%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack